Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Titel:
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
Auteur:
Bol, Kalijn F. Aarntzen, Erik H. J. G. Pots, Jeanette M. Olde Nordkamp, Michel A. M. Rakt, Mandy W. M. M. van de Scharenborg, Nicole M. Boer, Annemiek J. de Oorschot, Tom G. M. van Croockewit, Sandra A. J. Blokx, Willeke A. M. Oyen, Wim J. G. Boerman, Otto C. Mus, Roel D. M. Rossum, Michelle M. van Graaf, Chantal A. A. van der Punt, Cornelis J. A. Adema, Gosse J. Figdor, Carl G. Vries, I. Jolanda M. de Schreibelt, Gerty